These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9717 related articles for article (PubMed ID: 21348412)

  • 1. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
    Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
    Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
    J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited predisposition to cancer: a historical overview.
    Lynch HT; Shaw TG; Lynch JF
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing by cancer site: stomach.
    Chun N; Ford JM
    Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics and management strategies in hereditary cancer syndromes.
    Hanna NN; Mentzer RM
    J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary ovarian cancer.
    Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetics of hereditary breast carcinoma].
    Hampl M; Chang-Claude J; Schwarz P; Saeger HD; Schackert HK
    Zentralbl Chir; 1997; 122(2):67-73. PubMed ID: 9173760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing by cancer site: ovary.
    Weissman SM; Weiss SM; Newlin AC
    Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
    Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
    Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary gastric cancer.
    Oliveira C; Seruca R; Carneiro F
    Best Pract Res Clin Gastroenterol; 2009; 23(2):147-57. PubMed ID: 19414142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 486.